137 related articles for article (PubMed ID: 1987899)
1. [DNA analysis of breast cancer].
Ohuchi N; Mori S
Gan To Kagaku Ryoho; 1991 Jan; 18(1):30-6. PubMed ID: 1987899
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
Hara S; Tomita M
Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
[TBL] [Abstract][Full Text] [Related]
8. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material.
Bergers E; van Diest PJ; Baak JP
Anal Cell Pathol; 1995 Jan; 8(1):1-13. PubMed ID: 7734408
[TBL] [Abstract][Full Text] [Related]
11. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
12. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
14. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
Berho M; Viciana AL; Poppiti RJ; Ruiz P
J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
[TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 amplification in node-negative human breast cancer.
Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G
Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424
[TBL] [Abstract][Full Text] [Related]
16. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Hedley DW; Rugg CA; Gelber RD
Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
[TBL] [Abstract][Full Text] [Related]
17. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].
Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H
Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
19. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
